VALIANTLAB Share Price Performance
₹88.42
-35.66 (-28.74%)
Price ₹88.42
Share Price₹88.42
VALIANTLAB Community Narratives
There are no narratives available yet.
Recent VALIANTLAB News & Updates
No updates
Valiant Laboratories Limited Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.51
- Gross Margin
- 12.58%
- Net Profit Margin
- -1.65%
- Debt/Equity Ratio
- 51.7%
Valiant Laboratories Limited Competitors
About VALIANTLAB
- Founded
- 1980
- Employees
- 77
- CEO
- WebsiteView website
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP.
Indian Market Performance
- 7 Days: -1.6%
- 3 Months: 2.7%
- 1 Year: -6.5%
- Year to Date: -2.0%
Over the last 7 days, the market has dropped 1.6%, driven by a pullback of 2.1% in the Financials sector. In the last 12 months the market is down 6.5%. Earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading